A popular diabetes drug just got a major new approval—and it could be a game-changer for millions of Americans at risk for ...
Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...
The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular death among adults with type 2 diabetes and chronic kidney ...
Ozempic: Which Is Better for Weight ... tirzepatide on more than 11,000 people with type 2 diabetes. It found that doses of 5 milligrams (mg), 10 milligrams and 15 milligrams led to weight loss.
Ozempic is approved for type 2 diabetes, while its counterpart ... Zepbound and Mounjaro — that has the option to ‘hack’ the pen for a smaller dose," Dr. Alexandra Sowa, an obesity medicine ...
A recent study linked semaglutide to lower risks of Alzheimer's disease in people with type 2 diabetes. But it's too early to say that Ozempic can help Alzheimer’s, Castro-Tié tells PEOPLE.
Scientists find Ozempic may treat cancer, Alzheimer's and more. Is it hype or truly a "wonder drug?"
Few drugs have captured public attention like Ozempic; many of us have even taken it. The type 2 diabetes medication, generically known as semaglutide, has received unprecedented attention in the ...
You may take Ozempic or another drug to control your diabetes ... The research, which compared about 2 million veterans with diabetes, some of whom took the drugs and some didn't, found the ...
A major analysis of more than 1.2 million medical records has found popular diabetes and weight loss drugs, including Ozempic and Wegovy, may also reduce the risk of other health issues.
Ozempic-friendly foods hit market as industry rushes to capitalize — but are they actually needed?
Choi_ Nikolai - stock.adobe.com They’re not biting. As Ozempic and other GLP-1 drugs change the way America eats, food manufacturers are trying to whip themselves up a forkful of the action ...
Click Here To Sign Up For Our Health Newsletter Novo Nordisk, the maker of Ozempic (approved for type 2 diabetes treatment and reduced risk of cardiovascular events) and Wegovy (approved for ...
In a ginormous new study, researchers have begun mapping the manifold health benefits of drugs like Ozempic and Wegovy beyond weight loss. Published in the journal Nature Medicine, this new study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback